PBM
Psyence Biomedical Ltd.
There isn't enough reported data to score PBM yet.
PBM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate PBM's fundamentals.
PBM PE Valuation
PBM has no meaningful PE right now: it lost money over the past year.
PBM Forward outlook
There aren't enough analyst estimates for PBM to show an outlook.
PBM Earnings Per Share
PBM Quarterly Revenue
PBM Free Cash Flow
PBM Total Shares
PBM Net Leverage
PBM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PBM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.7 | Neutral |
| Stochastic | 9.4 | Oversold |
PBM's weekly RSI is 36 (neutral) and its Stochastic is 9 (oversold).
PBM PE vs Healthcare Sector
PBM has no meaningful PE right now: it lost money over the past year.
PBM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.18 | 26% below |
| 20 week MA | $4.03 | 23% below |
| 50 week MA | $4.30 | 28% below |
| 100 week MA | $19.8 | 84% below |
PBM is in a downtrend: it's below all four of its weekly moving averages, and 84% below its 100-week average.
PBM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $7,416.0 | $95.0 | -99% |
| 2025 | $95.0 | $5.82 | -94% |
| 2026 YTD | $5.82 | $3.09 | -47% |
PBM has finished every year since 2024 lower, and it's down 47% so far in 2026.